Central Vertigo

Educational clinical summary of Central Vertigo for doctors and students: definition, workup, management, and key caveats. Not a substitute for guidelines.

Maintained by Dr. Vivek Karn Review process: editorial policy

Overview

Definition

Central Vertigo refers to the sensation of spinning or swaying (vertigo) caused by dysfunction within the Central Nervous System (CNS), specifically pathways connecting the vestibular nuclei in the brainstem, the cerebellum, and the cerebral cortex. Unlike peripheral vertigo (which originates in the inner ear or vestibular nerve), central vertigo typically results from lesions (e.g., ischemia, hemorrhage, demyelination, tumor) affecting the central vestibular structures.

Epidemiology

The true incidence of central vertigo is difficult to ascertain as it is often a symptom of underlying neurological emergencies (e.g., stroke). * Stroke: Approximately 10%–25% of patients with acute ischemic stroke present with dizziness, and roughly 0.7% to 3% of emergency room visits for dizziness are attributable to posterior circulation stroke (POCS). * Acoustic Neuroma/Other CPA Tumors: Rare, but a significant cause of chronic, progressive central and peripheral symptoms. * Multiple Sclerosis (MS): Vertigo can be the presenting symptom in 5% of MS patients and commonly occurs during exacerbations.

Classification

Central vertigo is classified based on the etiology and location of the lesion: 1. Vascular: Posterior circulation ischemia (PICA, AICA, SCA territories), vertebrobasilar insufficiency, lacunar infarcts. 2. Demyelinating: Multiple Sclerosis (MS), acute disseminated encephalomyelitis (ADEM). 3. Neoplastic: Cerebellopontine angle (CPA) tumors (e.g., metastases, hemangioblastoma, meningioma) or intrinsic brainstem/cerebellar tumors. 4. Infectious/Inflammatory: Brainstem encephalitis, abscess. 5. Degenerative/Hereditary: Spinocerebellar ataxias (rarely), familial hemiplegic migraine.

Pathophysiology

Mechanism

Central vertigo arises from the disruption of the central processing of vestibular information. 1. Brainstem Lesions (e.g., Wallenberg Syndrome/Lateral Medullary Infarct): Affect the vestibular nuclei, inferior cerebellar peduncle, and surrounding tracts (like the medial longitudinal fasciculus – MLF). This disrupts integration of input from the vestibular nerve, resulting in severe vertigo, imbalance, and associated cranial nerve deficits. 2. Cerebellar Lesions (e.g., Cerebellar Infarct): The cerebellum modulates vestibular reflexes and gait control. Lesions, particularly in the nodulus and flocculus, interfere with balance and gaze stabilization, often leading to severe truncal ataxia and direction-changing or purely vertical nystagmus. 3. Mismatch: The core mechanism involves a fundamental pathological mismatch between vestibular information processed contralaterally in the CNS, leading to a central interpretation of spatial disorientation.

Risk Factors

Similar to risk factors for stroke and neurological disease: * Vascular: Advanced age, hypertension (most significant controllable risk factor), diabetes mellitus, hyperlipidemia, smoking, atrial fibrillation, cervical artery dissection, migraine history. * Structural: History of CNS tumor (primary or metastatic), known demyelinating disease (e.g., MS). * Genetic: Family history of movement disorders or stroke.

Protective Factors

Aggressive control of vascular risk factors (BP < 130/80 mmHg, HbA1c control, LDL reduction).
Antiplatelet and anticoagulation therapies in high-risk patients (e.g., post-TIA/stroke, AFib).
Healthy lifestyle (regular exercise, non-smoking, moderate alcohol consumption).

Clinical Presentation

Signs and Symptoms

Feature	Central Vertigo	Peripheral Vertigo (For Comparison)
Severity	Often less intense, but constant and long-lasting (days/weeks).	Often severe (room spinning), intermittent, short duration (seconds/minutes).
Balance/Gait	Severe Truncal Ataxia (may be unable to stand or walk), often out of proportion to the severity of vertigo.	Mild ataxia, generally able to walk (staggering toward the affected side).
Nausea/Vomiting	Variable/Mild.	Often severe.
Hearing Loss/Tinnitus	Rarely associated (if brainstem affected), usually not present.	Often associated (e.g., Meniere's, Labyrinthitis).
Associated Symptoms (The "D's")	Common: Diplopia, Dysarthria, Dysphagia, Hemiparesis/Sensory loss, Headache (often severe occipital or neck pain).	Rare, limited to otological symptoms.

Physical Examination

The core goal of the physical exam in acute vertigo is differentiating Central from Peripheral causes, often using the HINTS battery.

Inspection

Gait: Observe for profound truncal ataxia or lateropulsion favoring one side.
Nystagmus: Key differentiating feature:
- Direction: Often purely vertical, purely torsional, or direction-changing (reversing direction with lateral gaze, highly suggestive of central lesion).
- Fixation: Nystagmus is not suppressed by visual fixation (i.e., remains active even when the patient focuses on an object).

Special Tests (The HINTS Exam – Crucial for Acute Vestibular Syndrome)

The HINTS exam (Head Impulse, Nystagmus, Test of Skew) is performed in patients with Acute Vestibular Syndrome (acute, persistent vertigo lasting >24 hours, often with nausea/vomiting and spontaneous nystagmus).

Head Impulse Test (HIT): Tests the VOR (Vestibulo-Ocular Reflex).
- Peripheral Lesion: Abnormal (Saccade correction—eyes overshoot the target, then snap back).
- Central Lesion: Normal/Negative (Eyes remain fixed on the target, VOR intact). (H: Normal implies Central)
Nystagmus (N): Assessment of spontaneous nystagmus.
- Peripheral Lesson: Unidirectional, horizontal or horizontal-torsional, obeys Alexander's law (increases with gaze toward fast phase).
- Central Lesion: Direction-changing, pure vertical, or pure torsional. (N: Central type implies Central)
Test of Skew (S) (Vertical Ocular Misalignment): The cover/uncover test detects vertical ocular realignment (skew deviation) when covering one eye.
- Peripheral Lesion: Absent.
- Central Lesion: Present (highly specific for a brainstem lesion). (S: Skew implies Central)

Interpretation: * "HINTS-Plus": HINTS findings suggestive of Central Vertigo (Normal HIT, Central Nystagmus, Skew) PLUS presence of headache/hearing loss suggests possible PICA stroke or brainstem lesion. * "Dangerous HINTS": Any Central finding (Normal HIT, Central Nystagmus, Skew) suggests CNS pathology (high likelihood of stroke).

Diagnostic Approach

History Taking

Key Questions

Onset: Was the onset acute or gradual? (Acute favors stroke/demyelination; gradual favors tumor).
Duration: Is the vertigo episodic (minutes/hours) or persistent (days/weeks)? (Persistent is more concerning for central causes).
Associated Neurological Symptoms: Did the vertigo accompany double vision (diplopia), difficulty swallowing (dysphagia), garbled speech (dysarthria), or weakness/numbness? (Presence of these "D's" is highly suggestive of central pathology).
Vascular Risk Factors: History of hypertension, diabetes, hypercholesterolemia, atrial fibrillation?
Medications: Are they taking any CNS depressants (e.g., benzodiazepines, opioids)?

Red Flags (Warning signs requiring urgent attention)

Any unilateral focal neurological deficit (e.g., contralateral hemiparesis, ipsilateral facial weakness).
Severe Truncal Ataxia (inability to stand or walk without support).
New, severe headache or neck pain (thunderclap component).
Skew Deviation or Direction-Changing/Purely Vertical Nystagmus (Positive HINTS).
Acute, isolated vertigo of unknown cause in elderly patients with vascular risk factors.

Laboratory Tests

Laboratory tests are generally unhelpful for diagnosing acute central vertigo itself, but are crucial for investigating etiology:

First-Line:
- Complete Blood Count (CBC)
- Basic Metabolic Panel (BMP)
- Fasting Lipid Profile, Glucose/HbA1c (evaluating vascular risk factors)
- Troponin, ECG (ruling out cardiac embolism source).
Confirmatory (Specific Etiologies):
- Inflammatory/Demyelinating: Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein (CRP), Lyme serology, autoantibodies (if rheumatologic cause suspected).
- Lumbar Puncture (LP): If suspicion of MS (oligoclonal bands) or meningoencephalitis.

Imaging

Recommended (Acute Setting)

Magnetic Resonance Imaging (MRI) with Diffusion-Weighted Imaging (DWI): Imaging modality of choice for CNS pathology.
- Rationale: DWI is crucial for detecting acute ischemic stroke (sensitivity for posterior circulation stroke, however, can be limited in the acute phase, especially within the first 12–24 hours).
- Protocol: Brain MRI with FLAIR, T2, and DWI sequences. Ideally includes magnetic resonance angiography (MRA) of the head and neck vessels to assess for dissection, stenosis, or occlusion.
Computed Tomography (CT) Angiography (CTA):
- Rationale: Used primarily when MRI is unavailable or contraindicated, or when acute hemorrhage needs immediate exclusion. CTA provides rapid assessment of the posterior circulation arteries (vertebral and basilar arteries).

Advanced (Chronic or Refractory Cases)

Formal Neuro-Ophthalmology Consultation: For complex eye movement disorders (e.g., periodic alternating nystagmus, acquired pendular nystagmus).
Vestibular Evoked Myogenic Potentials (VEMPs): Can sometimes show central pathway involvement.

Management

Management depends entirely on the underlying etiology (e.g., stroke, MS relapse, tumor).

Acute Management (Focusing on Stroke/AVS)

Immediate (Within 1 Hour)

Rule out Hemorrhage: Stat non-contrast Head CT.
Triage/Transfer: If stroke is suspected, activate stroke team and transfer to a specialized stroke center.
Vascular Access & Monitoring: Establish IV, cardiac monitoring, and frequent neurological checks.

Stabilization

BP Management: Maintain blood pressure for cerebral perfusion, unless the patient is a candidate for reperfusion therapy (then strict guidelines apply, e.g., <185/110 mmHg for thrombolysis).
Airway/Breathing: Crucial in brainstem stroke due to potential involvement of respiratory or swallowing centers (bulbar signs). Intubation may be required.

Emergency (Stroke Reperfusion)

If acute ischemic stroke is confirmed and the patient meets criteria: * Intravenous Thrombolysis (IV tPA): 0.9 mg/kg (10% bolus, remainder over 1 hour), within 4.5 hours of symptom onset (after ruling out hemorrhage). * Endovascular Thrombectomy (EVT): Indicated for large vessel occlusion (LVO) in the posterior circulation, typically within a 6–24 hour window depending on collateral status and imaging findings.

Chronic Management

Pharmacological

Goal: Treat the underlying cause and manage persistent dizziness and nystagmus.

Antiplatelet/Anticoagulation (Stroke Prevention):
- Ischemic Stroke/TIA: Aspirin 81-325 mg daily, or dual antiplatelet therapy (Aspirin + Clopidogrel 75mg for 21-90 days), depending on etiology.
- Cardioembolic Stroke: Long-term anticoagulation (DOACs or Warfarin).
Symptomatic Suppression (Used sparingly, mainly during the acute phase):
- Antihistamines: Meclizine (25–50 mg PO Q6H) or Dimenhydrinate (50 mg PO Q4H). Note: These suppress the vestibular signal and should be tapered quickly to promote central compensation.
- Benzodiazepines: Lorazepam (0.5–1 mg PO prn) or Diazepam (2–5 mg PO prn). Use cautiously due to sedation and hindrance of vestibular rehabilitation.
Specific Etiologies:
- MS Relapse: High-dose corticosteroids (e.g., Methylprednisolone 1 gm IV daily for 3–5 days).
- Tumor: Surgical resection, radiation, or chemotherapy.

Non-Pharmacological

Vestibular Rehabilitation Therapy (VRT): Essential for chronic imbalance and gaze instability. Central lesions often require longer and more intensive VRT than peripheral lesions.
- Focus Areas: Gaze stability exercises (Varying light conditions, head movements), habituation exercises, balance and gait training (e.g., tandem walking, obstacle course).
Physical Therapy: For severe truncal ataxia.

Treatment Algorithms

Situation	First-Line Approach	Second-Line Approach
Acute Stroke (Ischemia)	IV Thrombolysis and/or Mechanical Thrombectomy (if eligible).	Aggressive risk factor modification (BP, statins, antiplatelets).
MS Relapse	High-dose IV/PO Corticosteroids.	Plasma exchange (PLEX) if refractory.
Chronic Instability/Dizziness	Vestibular Rehabilitation Therapy (VRT).	Low-dose centrally acting suppressants (e.g., Clonazepam 0.5 mg daily) combined with VRT.

Complications

Common

Persistent Vestibular Symptoms: Chronic dizziness, oscillopsia (visual blurring with head movement), and motion sickness prophylaxis dependence.
Anxiety and Depression: Related to functional impairment and fear of recurrence.

Serious

Stroke Recurrence: High risk if underlying vascular risk factors are untreated.
Aspiration Pneumonia: Due to bulbar dysfunction (dysphagia) in brainstem strokes.
Falls and Injury: Secondary to severe truncal ataxia and imbalance.

Long-term

Permanent Neurological Deficits: Hemiparesis, sensory loss, diplopia, chronic imbalance impacting quality of life.

Prognosis

Factors

Etiology: Prognosis is highly dependent on the underlying cause. Prognosis for transient demyelination (MS) is better than for large established stroke or aggressive tumors.
Lesion Size and Location: Small lacunar infarcts may resolve completely; large brainstem or cerebellar involvement carries high morbidity and mortality.
Age and Comorbidities: Older patients and those with multiple vascular risk factors have poorer outcomes.
Rehabilitation: Early and continuous VRT significantly improves long-term functional recovery.

Quality of Life

Central vertigo lesions (especially cerebellar) often result in persistent severe gait instability (truncal ataxia) that is frequently more disabling than the vertigo sensation itself, severely limiting the ability to return to work or independent living.

Prevention

Primary

Vascular Risk Management: Comprehensive control of hypertension, diabetes, hyperlipidemia. Smoking cessation.
Avoidance of Ototoxic Medications: Monitoring drug levels (e.g., aminoglycosides) to prevent inner ear damage, which can sometimes interact with central lesions.

Secondary

Post-Stroke Care: Institution of antiplatelet/anticoagulation therapy, high-intensity statins (e.g., Atorvastatin 80 mg daily).
Early Recognition: Providers must maintain a high index of suspicion for stroke in patients presenting with acute vestibular syndrome, especially with atypical nystagmus or focal signs.

Special Populations

Geriatric

Higher Stroke Risk: Central vertigo due to POCS is disproportionately common in the elderly.
Polypharmacy: Increased risk of drug interactions and side effects from vestibular suppressants.
Atypical Presentation: Symptoms may be vague ("dizziness," "lightheadedness") rather than classical spinning vertigo, requiring careful bedside neurological examination (HINTS).

Comorbidities (Migraine/Stroke)

Migraine-Associated Vertigo (MAV): Must be differentiated from stroke. MAV vertigo episodes are typically shorter, associated with headache/photophobia, and neurological signs are often transient and resolve with migraine treatment (e.g., CGRP inhibitors, Topiramate). Distinguishing acute MAV from stroke requires careful use of MRI and HINTS.

Clinical Pearls

Diagnostic

The HINTS Rule: Used effectively, the HINTS examination is superior to early MRI/CT in detecting posterior circulation stroke in the first 24-48 hours. A Normal Head Impulse Test in the setting of acute, continuous vertigo is a sign of central compromise (Stroke until proven otherwise).
Beware of "Isolated Vertigo": While rare, isolated acute vertigo can be the sole manifestation of cerebellar or lateral medullary infarction. A high clinical suspicion based on risk factors and HINTS is paramount.
Tilt-Suppression of BPPV: BPPV (a peripheral cause) typically causes nystagmus fixation suppression (nystagmus decreases when eyes are fixed on a target), while central nystagmus is not suppressible.

Treatment

Limit Vestibular Suppressants: Benzodiazepines and antihistamines should be used only for severe, acute symptoms and then rapidly withdrawn (ideally within 48–72 hours) to maximize central compensation and the efficacy of VRT.
Aggressive Risk Factor Control: Treatment of the lesion (e.g., thrombolysis) must be matched by immediate and long-term secondary stroke prevention measures.

Pitfalls

Misinterpreting Peripheral Nystagmus: Assuming all horizontal-torsional nystagmus is peripheral. Cerebellar lesions can mimic peripheral patterns but often lack fixations suppression.
Over-reliance on Normal CT: CT scans are poor at detecting posterior fossa ischemia; a patient with a strong clinical picture for stroke needs MRI/DWI.

Recent Updates

Guidelines

AHA/ASA Guidelines on Stroke Prevention: Current guidelines emphasize high-intensity statin therapy (e.g., Atorvastatin 80 mg) and blood pressure control as cornerstones of secondary prevention for POCS.
HINTS Usage: The utility of the HINTS exam has been validated as a critical tool for differentiating benign from dangerous causes of Acute Vestibular Syndrome, recommending its routine use by emergency physicians and neurologists.

Evidence

MRI Sensitivity: While MRI/DWI remains the gold standard, recent data confirms that its sensitivity for acute POCS can be as low as 80% in the first 24 hours. A negative early MRI does not definitively exclude stroke if the clinical context (HINTS, risk factors) is concerning.

Key References

Guidelines: American Heart Association/American Stroke Association (AHA/ASA) Guidelines for the Early Management of Patients with Acute Ischemic Stroke (2019/2021 updates).
Studies: Kattah, J. C., et al. (2009). "HINTS to diagnose stroke in the acute vestibular syndrome." Stroke. (Landmark paper validating HINTS).
Reviews: References specific to posterior circulation stroke and central vestibular disorders published in Neurology and Journal of Neurology.

Disclaimer: This information is provided for clinical reference and educational purposes only. It is not a substitute for professional medical judgment, diagnosis, or treatment. Clinicians must apply individual patient assessment and current institutional protocols.